Speaking about Big Pharma's splurge into M&A and collaborations - this is the current list of collaborations from this weekend:
(therapeutic area, upfront fee)
1) Pfizer-Beam (base editing, $300m)
2) Exact-PreventionGenetics (genetics testing, $190m M&A)
3) Acadia-Stoke (rare disease, $60m)
4) Moderna-Carisma (in vivo CAR-M, $45m)
5) Bayer-Mammoth (gene editing, $40m)
6) BMS-Century (IPSC iNK & T-Cell, 100m)
I got this list from someone from twitter - crazy weekend.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $13.01M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $17.15K | 5.329M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 24321911 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 74921364 | 40 |
View Market Depth
| Last trade - 16.10pm 13/08/2025 (20 minute delay) ? |
| CHM (ASX) Chart |